The Impact of Training on Self-Efficacy, Symptom Level, and Activities of Daily Living
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIstanbul Saglik Bilimleri University
About this trial
This study is a randomized, controlled experimental trial with a pretest-posttest design, conducted to evaluate the effects of Pecha Kucha-based education on self-efficacy, symptom level, and activities of daily living in individuals diagnosed with chronic obstructive pulmonary disease (COPD) receiving noninvasive mechanical ventilation support.
The study will include two groups, and intergroup differences will be evaluated:
1. Control group 2. Intervention group
Study Hypotheses H1: Pecha Kucha-based education on noninvasive mechanical ventilation (NIMV) support provided to individuals with chronic obstructive pulmonary disease (COPD) increases patients' self-efficacy levels.
H2: Pecha Kucha-based education on noninvasive mechanical ventilation (NIMV) support provided to individuals with chronic obstructive pulmonary disease (COPD) reduces patients' symptom levels.
H3: Pecha Kucha-based education on noninvasive mechanical ventilation (NIMV) support provided to individuals with chronic obstructive pulmonary disease (COPD) improves patients' activities of daily living.
Eligibility criteria
Qualifiers
Age 18 years or older
Diagnosed with chronic obstructive pulmonary disease (COPD) at least one year prior
Currently receiving treatment with noninvasive mechanical ventilation (NIMV) support
Ability to communicate verbally and in writing in a clear and sustainable manner
Disqualifiers
Failure to attend planned educational sessions or inability to complete the study protocol
Voluntary withdrawal from the study, declared verbally or in writing
Death during the study period
Development of a serious health condition preventing continuation in the education program (e.g., hospitalization, acute exacerbation, deterioration in mental status)
Trial design
Treatments tested in this trial
- Intervention Group
Treatment groups
60 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov